Skip to main content

Table 4 Population clinical and laboratory characteristics according to Mets diagnosis based on ApoE E4 allele presence

From: Diversity of Apolipoprotein E genetic polymorphism significance on cardiovascular risk is determined by the presence of Metabolic Syndrome among hypertensive patients

 

MetS (+) n = 266

MetS (−) n = 117

 

E4 allele (−)

E4 allele (+)

N

E4 allele (−)

E4 allele (+)

N

Men

92 (42.0%)

21 (44.7%)

NS

49 (52.7%)

14 (58.3%)

NS

Age (years)

64.4 ± 11.3

62.5 ± 12.5

NS

63.1 ± 12.7

64.8 ± 13.1

NS

White

131 (59.8%)

37 (78.7%)

< 0,05

55 (59.8%)

13 (54.2%)

NS

Weight (kg)

82.8 ± 57.7

79.0 ± 16.8

NS

68.9 ± 14.0

69.5 ± 14.0

NS

BMI (kg/cm2)

30.6 ± 4.9

30.5 ± 6.4

NS

26.6 ± 5.8

26.6 ± 5.3

NS

Waist (cm)

104.4 ± 11.6

104.6 ± 13.5

NS

91.1 ± 13.4

91.0 ± 13.0

NS

DM

114 (52.1%)

25 (53.2%)

NS

21 (22.8%)

6 (25.0%)

NS

Dislipidemia

184 (84.0%)

41 (87.2%)

NS

63 (67.7%)

16 (66.7%)

NS

CVD

75 (34.7%)

24 (51.1%)

< 0,05

27 (30.0%)

2 (8.3%)

< 0.05

Sedentarism

171 (80.7%)

34 (75.6%)

NS

69 (76.7%)

20 (87.0%)

NS

Smoking

30 (14.0%)

4 (8,5%)

NS

8 (8.7%)

3 (13.6%)

NS

Alcohol

16 (7.5%)

2 (4,3%)

NS

7 (7.7%)

3 (13.0%)

NS

Chol (mg/dl)

182.2 ± 42.2

179.4 ± 41.5

NS

186.5 ± 37.1

170.0 ± 27.5

< 0.05

HDL-c (mg/dl)

43.0 ± 9.8

40.5 ± 10.4

NS

56.2 ± 15.7

52.9 ± 11.4

NS

LDL-c (mg/dl)

105.9 ± 35.4

104.1 ± 33.2

NS

109.6 ± 31.3

93.3 ± 20.5

< 0.05

TG (mg/dl)

168.2 ± 80.1

184.3 ± 94.3

NS

108.5 ± 69.8

117.8 ± 71.6

NS

Cr (mg/dl)

1.48 ± 0.92

1.36 ± 0.70

NS

1.43 ± 0.77

1.51 ± 1.09

NS

U (mg/dl)

59.6 ± 31.9

55.4 ± 31.6

NS

57.9 ± 29.7

60.2 ± 36.2

NS

CRP (mg/dl)

0.63 ± 0.80

0.61 ± 0.81

NS

0.41 ± 0.52

0.32 ± 0.49

NS

  1. BMI: body mass index; DM: diabetes mellitus; Chol: total cholesterol; HDL-C: HDL cholesterol; LDL-c: LDL cholesterol; TG: Triglycerides; Cr: creatinine; U: urea; CRP: C reactive protein C. p: NS, non significant.